A Dipeptidyl Peptidase-4 Inhibitor Suppresses Macrophage Foam Cell Formation in Diabetic db/db Mice and Type 2 Diabetes Patients

A Dipeptidyl Peptidase-4 Inhibitor Suppresses Macrophage Foam Cell Formation in Diabetic db/db Mice and Type 2 Diabetes Patients

Dipeptidyl peptidase-4 (DPP-4) inhibitors could have antiatherosclerotic action, in addition to antihyperglycemic roles. Because macrophage foam cells are key components of atherosclerosis, we investigated the effect of the DPP-4 inhibitor teneligliptin on foam cell formation and its related gene ex...

Full description

Saved in:

Bibliographic Details
Main Authors:	Michishige Terasaki, Munenori Hiromura, Yusaku Mori, Kyoko Kohashi, Hideki Kushima, Masakazu Koshibu, Tomomi Saito, Hironori Yashima, Takuya Watanabe, Tsutomu Hirano
Format:	Article
Language:	English
Published:	Wiley 2018-01-01
Series:	International Journal of Endocrinology
Online Access:	http://dx.doi.org/10.1155/2018/8458304
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Combination Therapy with a Sodium-Glucose Cotransporter 2 Inhibitor and a Dipeptidyl Peptidase-4 Inhibitor Additively Suppresses Macrophage Foam Cell Formation and Atherosclerosis in Diabetic Mice
by: Michishige Terasaki, et al.
Published: (2017-01-01)

Retinal Neurodegeneration in db/db Mice at the Early Period of Diabetes
by: Qin Yang, et al.
Published: (2015-01-01)

Multi-omics characterization of diabetic nephropathy in the db/db mouse model of type 2 diabetes
by: Liping Wang, et al.
Published: (2025-01-01)

Transcriptional Profile of Kidney from Type 2 Diabetic db/db Mice
by: Haojun Zhang, et al.
Published: (2017-01-01)

Differential effects of S-allyl cysteine and cannabidiol on enterocytic and plasma amyloid-β in db/db diabetic mice
by: Arazu Sharif, et al.
Published: (2025-07-01)

Sodium Meta-Arsenite Ameliorates Hyperglycemia in Obese Diabetic db/db Mice by Inhibition of Hepatic Gluconeogenesis
by: Young-Sun Lee, et al.
Published: (2014-01-01)

Effects of switching from dipeptidyl peptidase 4 inhibitors to oral semaglutide on oxidative stress and glycemic variability in patients with type 2 diabetes: an open-label, prospective, randomized, multicenter, parallel-group comparison study
by: Makoto Ohara, et al.
Published: (2025-04-01)

Apoptosis in the liver of male <em>db/db</em> mice during the development of obesity and type 2 diabetes
by: S. V. Michurina, et al.
Published: (2020-07-01)

Sarpogrelate hydrochloride ameliorates diabetic nephropathy associated with inhibition of macrophage activity and inflammatory reaction in db/db mice.
by: Eun Soo Lee, et al.
Published: (2017-01-01)

Irbesartan Ameliorates Diabetic Nephropathy by Suppressing the RANKL-RANK-NF-κB Pathway in Type 2 Diabetic db/db Mice
by: Xiao-Wen Chen, et al.
Published: (2016-01-01)

Therapeutic Potential of Myricitrin in a <i>db</i>/<i>db</i> Mouse Model of Type 2 Diabetes
by: Sang Ryong Kim, et al.
Published: (2025-03-01)

Oral Sulforaphane Intervention Protects Against Diabetic Cardiomyopathy in db/db Mice: Focus on Cardiac Lipotoxicity and Substrate Metabolism
by: Pan Wang, et al.
Published: (2025-05-01)

Dipeptidyl peptidase-4 inhibitors: their role in the management of type 2 diabetes
by: Gail Mkele
Published: (2013-12-01)

Differential Analysis of Oral Microbiota in db/db Mouse Model of Type 2 Diabetes Utilizing 16S rRNA Sequencing
by: PAN Qianjia, et al.
Published: (2025-04-01)

Glycyrrhizic Acid Prevents Diabetic Nephropathy by Activating AMPK/SIRT1/PGC-1α Signaling in db/db Mice
by: Shaozhang Hou, et al.
Published: (2017-01-01)

M2 macrophage infusion ameliorates diabetic glomerulopathy via the JAK2/STAT3 pathway in db/db mice
by: Yulin Gu, et al.
Published: (2024-12-01)

Fufang Zhenzhu Tiaozhi capsule attenuates renal damage by restoring Th17/Treg balance in diabetic db/db mice
by: Yiqi YANG, et al.
Published: (2022-03-01)

Mechanistic insights into the PAI-1 inhibitor PAItrap3: enhancing lipid metabolism in adipose tissue of diabetic db/db mice
by: Linxi Wang, et al.
Published: (2025-06-01)

Salidroside alleviates ferroptosis of retinal ganglion cells in db/db mice
by: Wenqiang Liu, et al.
Published: (2025-06-01)

Ultrasonographic Characterization of the db/db Mouse: An Animal Model of Metabolic Abnormalities
by: Francesco Faita, et al.
Published: (2018-01-01)

Nootkatone Alleviates Type 2 Diabetes in db/db Mice Through AMPK Activation and ERK Inhibition: An Integrated In Vitro and In Vivo Study
by: Yingjie Li, et al.
Published: (2025-05-01)

Dipeptidyl peptidase-1 inhibitors in bronchiectasis
by: Emma Johnson, et al.
Published: (2025-06-01)

Vascular endothelial growth factor-receptor 1 inhibition aggravates diabetic nephropathy through eNOS signaling pathway in db/db mice.
by: Keun Suk Yang, et al.
Published: (2014-01-01)

Type 2 diabetes worsens the outcome of ischemia/reperfusion in female STEMI patients and female db/db mice with HFpEF cardiometabolic phenotype
by: Ivana Iveljic, et al.
Published: (2025-06-01)

Trametenolic Acid Ameliorates the Progression of Diabetic Nephropathy in db/db Mice via Nrf2/HO-1 and NF-κB-Mediated Pathways
by: Qi Duan, et al.
Published: (2022-01-01)

Wenyang Jiedu Tongluo formula ameliorates diabetic kidney disease by regulating JAML/SIRT1 signaling to improve lipid metabolism in db/db mice
by: Yutong Liu, et al.
Published: (2025-08-01)

Coordinate Transcriptomic and Metabolomic Effects of the Insulin Sensitizer Rosiglitazone on Fundamental Metabolic Pathways in Liver, Soleus Muscle, and Adipose Tissue in Diabetic db/db Mice
by: Sabrina Le Bouter, et al.
Published: (2010-01-01)

SAFETY PROFILE OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS
by: M. Ganeva
Published: (2023-03-01)

Comparative Study of Seven New Dressings in Promoting Chronic Wound Healing in db/db Mice
by: Qiuyun FENG, et al.
Published: (2025-05-01)

Spermine: A prospective treatment for high glucose-induced myocardial fibrosis in db/db mice
by: Yong Liu, et al.
Published: (2025-07-01)

The role of dipeptidyl peptidase 4 inhibitors in fat metabolism in patients with type 2 diabetes and obesity
by: Aleksander Sergeevich Ametov, et al.
Published: (2015-10-01)

Renoprotective Effects of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin: A Review in Type 2 Diabetes
by: Cristina Mega, et al.
Published: (2017-01-01)

WCN25-695 Defective natriuresis contributes to hyperkalemia in db/db mice during potassium supplementation
by: Peng Wu, et al.
Published: (2025-02-01)

SugiExDB: data repository for Cryptomeria japonica RNA-sequencing read counts in TogoDB
by: Naoki Takata, et al.
Published: (2025-06-01)

Urate-lowering effects of dipeptidyl peptidase-4 inhibitors
by: Taras S. Panevin, et al.
Published: (2020-12-01)

Overexpression of lipoic acid synthase gene alleviates diabetic nephropathy of Leprdb/db mice
by: Tingting Yan, et al.
Published: (2021-03-01)

db/db Mice Exhibit Features of Human Type 2 Diabetes That Are Not Present in Weight-Matched C57BL/6J Mice Fed a Western Diet
by: Susan J. Burke, et al.
Published: (2017-01-01)

Celastrol, an NF-κB inhibitor, improves insulin resistance and attenuates renal injury in db/db mice.
by: Jung Eun Kim, et al.
Published: (2013-01-01)

Sex-Specific Impairments in Thermogenesis and Cold Tolerance in db/db Mice: Insights Into Obesity-Associated Thermogenic Dysfunction
by: Xinyun Xu, et al.
Published: (2025-05-01)

Effects of E2HSA, a Long-Acting Glucagon Like Peptide-1 Receptor Agonist, on Glycemic Control and Beta Cell Function in Spontaneous Diabetic db/db Mice
by: Shaocong Hou, et al.
Published: (2015-01-01)